Mark W Sawicki is Chief Scientific Officer of Cryoport, Inc.. Currently has a direct ownership of 77,444 shares of CYRX, which is worth approximately $508,807. The most recent transaction as insider was on Mar 25, 2024, when has been sold 1,367 shares (Common Stock) at a price of $17.54 per share, resulting in proceeds of $23,977. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.4K
0% 3M change
5.91% 12M change
Total Value Held $508,807

Mark W Sawicki Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2024
SELL
Open market or private sale
$23,977 $17.54 p/Share
1,367 Reduced 1.73%
77,444 Common Stock
Mar 15 2024
SELL
Open market or private sale
$20,244 $15.43 p/Share
1,312 Reduced 1.76%
73,061 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
5,750 Added 6.8%
78,811 Common Stock
Mar 11 2024
SELL
Open market or private sale
$23,184 $16.35 p/Share
1,418 Reduced 1.87%
74,373 Common Stock
Mar 09 2024
BUY
Exercise of conversion of derivative security
-
2,666 Added 3.4%
75,791 Common Stock
Sep 12 2023
BUY
Exercise of conversion of derivative security
$12,790 $12.79 p/Share
1,000 Added 1.35%
73,125 Common Stock
Mar 22 2023
BUY
Grant, award, or other acquisition
-
10,455 Added 12.66%
72,125 Common Stock
Mar 15 2023
SELL
Open market or private sale
$28,315 $20.79 p/Share
1,362 Reduced 2.16%
61,670 Common Stock
Mar 13 2023
SELL
Open market or private sale
$29,726 $20.14 p/Share
1,476 Reduced 2.29%
63,032 Common Stock
Mar 09 2023
BUY
Exercise of conversion of derivative security
-
2,667 Added 3.97%
64,508 Common Stock
Mar 14 2022
BUY
Grant, award, or other acquisition
-
10,455 Added 14.46%
61,841 Common Stock
Mar 09 2022
SELL
Open market or private sale
$43,780 $31.05 p/Share
1,410 Reduced 2.67%
51,386 Common Stock
Mar 09 2022
BUY
Exercise of conversion of derivative security
-
2,667 Added 4.81%
52,796 Common Stock
Aug 11 2021
SELL
Open market or private sale
$4,736,628 $59.1 p/Share
80,146 Reduced 61.52%
50,129 Common Stock
Aug 11 2021
BUY
Exercise of conversion of derivative security
$775,282 $8.23 p/Share
94,202 Added 41.97%
130,275 Common Stock
Mar 10 2021
SELL
Open market or private sale
$733,072 $54.99 p/Share
13,331 Reduced 26.98%
36,073 Common Stock
Mar 10 2021
BUY
Exercise of conversion of derivative security
$82,699 $2.72 p/Share
30,404 Added 38.1%
49,404 Common Stock
MWS

Mark W Sawicki

Chief Scientific Officer
Brentwood, TN

Track Institutional and Insider Activities on CYRX

Follow Cryoport, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYRX shares.

Notify only if

Insider Trading

Get notified when an Cryoport, Inc. insider buys or sells CYRX shares.

Notify only if

News

Receive news related to Cryoport, Inc.

Track Activities on CYRX